Effective strategies for early detection of cognitive decline, if deployed on a large scale,
would have individual and societal benefits. However, current detection methods are …

The identification of biological and pathophysiological processes implicated in different
forms of dementia is itself dependent on reliable descriptions of cognitive performance and …

Neurodegenerative disorders (ND) are a common cause of mortality and morbidity
worldwide, particularly in older people. As life spans continue to increase, the incidence of …

Current state-of-the-art diagnostic measures of Alzheimer's disease (AD) are invasive
(cerebrospinal fluid analysis), expensive (neuroimaging) and time-consuming …

Access to affordable, objective and scalable biomarkers of brain function is needed to
transform the healthcare burden of neuropsychiatric and neurodegenerative disease …

Background: A clinical diagnosis of cognitive impairment is traditionally based on a single
cognitive exam, but serial cognitive testing can be sensitive to subtle cognitive changes in …

With the advent of advances in biomarker detection and neuropsychological measurement,
prospects have improved for identifying and tracking the progression of Alzheimer's disease …

The demand for rapidly administered, sensitive, and reliable cognitive assessments that are
specifically designed for identifying individuals in the earliest stages of cognitive decline …

This study aimed to identify baseline features of normal subjects that are associated with
subsequent cognitive decline. Publicly available data from the Alzheimer's Disease …

BACKGROUND: Progressive intraindividual decline in memory and cognition is
characteristic of dementia and may be useful in detecting very early Alzheimer's disease …